Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2008

View Archived Issues

FDA advisory committee recommends approval of Chugai and Roche's Actemra in RA

Integrated BioPharma sets record and distribution dates for spin-off of iBioPharma

[11C]-AFM, a novel PET imaging agent to visualize serotonin transporters

FDA accepts for filing Meda's registration application for Sublinox

Zogenix secures financing to launch sumatriptan DosePro

Chroma Therapeutics' CHR-3996 histone deacetylase inhibitor to be evaluated in a phase I study

Phase II results of AL-108 for amnestic MCI presented at ICAD meeting

Novel GSK-3 inhibitor increases neuron survival and attenuates neuropathology in transgenic AD mice

Millennium presents an update on clinical development

Pronucleon peptide technology effective for beta amyloid imaging in mice

Lexicon reports results from phase I study of LX-1031 in IBS

Inspire modifies clinical protocol for phase III TIGER-2 trial of denufosol tetrasodium in CF

Intercept completes USD 25 million equity financing

GSK launches Volibris for pulmonary arterial hypertension in the U.K.

Ariad initiates phase II clinical trial of deforolimus in breast cancer

Hollis-Eden initiates phase I/II clinical trial of Apoptone in late-stage prostate cancer

FDA approves Noven's Stavzor for bipolar disorder, seizures and migraine headaches

Novel antiinfective agents reported in recent patents

Idenix presents an update on the company's clinical development plans

Bristol-Myers Squibb prepares and tests novel factor VIIa inhibitors

New agents for diagnosis of congestive heart failure described in BMS patent

ReceptoPharm successfully completes phase IIb/IIIa clinical trial of RPI-78M in AMN

Regulatory approval of Basilea's Toctino recommended under European decentralized procedure

Infinity initiates phase I clinical trial of IPI-493 in advanced solid tumors

Othera submits IND application to FDA for OT-730 in glaucoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...